SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-22-023785
Filing Date
2022-06-21
Accepted
2022-06-21 17:15:37
Documents
14
Period of Report
2022-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A tcon-8ka_20220621.htm   iXBRL 8-K/A 47646
2 EX-5.1 tcon-ex51_6.htm EX-5.1 27497
3 GRAPHIC gekuefeawetp000001.jpg GRAPHIC 3262
  Complete submission text file 0001564590-22-023785.txt   220732

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcon-20220621.xsd EX-101.SCH 5605
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20220621_lab.xml EX-101.LAB 20036
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20220621_pre.xml EX-101.PRE 11934
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8ka_20220621_htm.xml XML 4800
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36818 | Film No.: 221029051
SIC: 2836 Biological Products, (No Diagnostic Substances)